Amar Vennapusa, a bariatric surgeon, fills a syringe with Eli Lilly’s Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, at his health clinic in Hyderabad, India, April 14, 2025. REUTERS/Almaas Masood
Amar Vennapusa, a bariatric surgeon, fills a syringe with Eli Lilly’s Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, at his health clinic in Hyderabad, India, April 14, 2025. REUTERS/Almaas Masood